Between September 2 and September 18, eight children died in Chhindwara, Maharashtra, due to kidney failure.
The deaths were initially overlooked until the death of Vikas (5) prompted a renal biopsy, revealing damage to the nephrons.
Suspicion arose regarding contamination in a cough syrup, reminiscent of a similar case in Gambia.
The Madhya Pradesh government halted the sale of a cough syrup found to contain Diethylene Glycol, an industrial chemical.
A door-to-door health survey is underway in the Parasia block of Chhindwara, with approximately 25,000 children under 5.
Coldrif Syrup, manufactured by Sresan Pharmaceutical, was found to be 'Not of Standard Quality' due to the presence of Diethylene Glycol.
Kataria Pharmaceuticals ordered 660 bottles of the syrup, with 594 sold in Chhindwara.
Detailed Insights:
Initial reluctance to conduct postmortem reports due to lack of parental consent hindered the investigation, highlighting the need for toxicology reports.
Renal biopsies revealed damage to the nephrons, the functional units of the kidney, leading to suspicion of cough syrup contamination.
Despite efforts to monitor children's health through local camps, parents sought treatment in Nagpur, taking them outside the monitoring system.
A door-to-door survey in Parasia found 4,658 children with symptoms of vomiting, cough, and viral fever, but initial kidney and liver tests came back normal.
The Office of the Controller, Food and Drugs Administration, MP, issued a directive regarding Coldrif Syrup after a test revealed the presence of Diethylene Glycol.
Diethylene Glycol, an industrial chemical, was found in the cough syrup at 48.6% by volume, leading to the halt of sales.
The incident highlights the critical importance of stringent quality control measures in pharmaceutical manufacturing and distribution.
Key Concepts Involved:
Nephrons: Functional units of the kidney responsible for filtering blood and producing urine.
Diethylene Glycol: An industrial chemical, toxic if ingested, sometimes found as a contaminant in pharmaceutical products.
Renal Biopsy: Examination of kidney tissue to determine the cause of kidney dysfunction or disease.